reports
Net Asset Value(s)
Net Asset Value(s) WisdomTree Issuer plc – Daily Fund Prices 18-April-24 WisdomTree Artificial Intelligence UCITS ETF - USD Acc18/04/2024IE00BDVPNG1314054630USD835,570,524.6559.4516WisdomTree AT1 CoCo Bond UCITS ETF - EUR Hedged18/04/2024IE00BFNNN2361662036EUR135,181,872.6981.3351WisdomTree AT1 CoCo Bond UCITS ETF - GBP Hedged18/04/2024IE00BFNNN459171509GBP14,601,965.1385.1382WisdomTree AT1 CoCo Bond UCITS ETF - USD18/04/2024IE00BZ0XVF52703178USD57,196,455.7381.3399WisdomTree AT1 CoCo Bond UCITS ETF - USD Acc18/04/2024IE00BZ0XVG6950789USD5,668,505.09111.6089WisdomTre...
- ABGSC IT Research
- Oscar Rönnkvist
- Simon Jönsson
Himax Joins Forces with E Ink to Revolutionize Smart Retail with Premi...
Himax Joins Forces with E Ink to Revolutionize Smart Retail with Premier of WiseEye™ AI at 2024 Touch Taiwan Powering Game-Changing Advancement in Immersive Shopping Experience with Ultralow Power Context-Aware AI for Battery Operated Signage EPD and ESL TAINAN, Taiwan and HSINCHU, Taiwan, April 19, 2024 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced a collaboration with E Ink Holdings Inc. (“E Ink"), a pioneer and distinguished leader in ...
- Soomit Datta
ADYEN (Buy, TP: EUR1,800, +27%) Rise of the Merchants: Shifts in Inte...
As part of our accelerated efforts in Payments, our latest Deep Dive focuses on Interchange and the implications for Adyen and peers. The current narrative suggests it's not relevant for future profitability. We would refute this simplification: there are risks and opportunities for Adyen.
- ABGSC Services Research
- Stefan Knutsson
EQS-News: Mit Cholesterin-Screening dem Herzinfarkt und Schlaganfall v...
EQS-News: Novartis Pharma GmbH / Schlagwort(e): Kooperation Mit Cholesterin-Screening dem Herzinfarkt und Schlaganfall vorbeugen: Novartis und die Charité erarbeiten neues Versorgungskonzept 19.04.2024 / 10:15 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Mit Cholesterin-Screening dem Herzinfarkt und Schlaganfall vorbeugen: Novartis und die Charité erarbeiten neues Versorgungskonzept Neues Präventionsmodell soll in Kooperation mit dem Friede Springer – Cardiovascular Prevention Center an der Charité in Berlin umgesetzt werden ...
Aktietilbagekøbsprogram
Aktietilbagekøbsprogram Nørresundby, 19. april 2024Meddelelse nr. 22/2024 Bestyrelsen i RTX har, jf. selskabsmeddelelse nr. 20/2023 af 30. november 2023, besluttet at iværksætte et aktietilbagekøbsprogram i overensstemmelse med bestemmelserne i artikel 5 i Europa-Parlamentets og Rådets forordning (EU) nr. 596/2014 af 16. april 2014 (MAR) og Kommissionens delegerede forordning (EU) 2016/1052, også kaldet "Safe Harbor"-forordningen. Under programmet vil RTX tilbagekøbe aktier for et beløb på op til DKK 20 mio. i perioden fra 1. december 2023 til 30. september 2024. Følgende transaktioner e...
Share repurchase programme
Share repurchase programme Nørresundby, 19 April 2024Announcement no. 22/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated 30 November 2023, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission’s delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbor" regulation. Under the programme RTX will buy back shares for an amount up to DKK 20 million in the period from 1 December 2023 to ...
Hexagon Purus ASA: Invitation to the presentation of first quarter 202...
Hexagon Purus ASA: Invitation to the presentation of first quarter 2024 results Hexagon Purus ASA's first quarter results 2024 will be released on 3 May 2024, 07:00 CET. Morten Holum (CEO) and Salman Alam (CFO) will present the results at 08:30 CET and the presentation will be broadcasted live via . The presentation will be held in English and will be virtual. A recording of the presentation will be made available on For more information: Mathias Meidell, IR Director, Hexagon Purus ASATelephone: +47 909 82 242 | Salman Alam, CFO, Hexagon Purus ASA Telephone: +47 476 12 713 | Ab...
Atlassian Corp: 2 directors
Two Directors at Atlassian Corp sold 16,482 shares at between 196.259USD and 196.259USD. The significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Origin Energy Ltd: 1 director
A director at Origin Energy Ltd sold 211,000 shares at 9.600AUD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- Bruno Cavalier
- Maissa Keskes
- Stephane Houri
HEIA HEINEKEN NV
VIE VEOLIA ENVIRONNEMENT SA
EDEN EDENRED SA
SU SCHNEIDER ELECTRIC SE
BNP BNP PARIBAS SA CLASS A
ABB ABB LTD.
SW SODEXO SA
RHM RHEINMETALL AG
KBC KBC GROUP N.V.
NOKIA NOKIA OYJ
EL ESSILORLUXOTTICA SA
AMUN AMUNDI SA
OR L'OREAL SA
SCHP SCHINDLER HOLDING AG PREF
EZJ EASYJET PLC
VOD VODAFONE GROUP PLC
WDP WAREHOUSES DE PAUW SCA
SHEL SHELL PLC
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
AGN AEGON N.V.
Samsara Inc: 2 directors
Two Directors at Samsara Inc sold 192,000 shares at between 30.732USD and 30.732USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Elanders AB: Quarterly Report January – March 2024
Elanders AB: Quarterly Report January – March 2024 First quarter 2024 Net sales amounted to MSEK 3,268 (3,589), which corresponded to an organic net sales reduction of nine percent, excluding acquisitions and discontinued operations, and using unchanged exchange rates. The reduction is primarily a result of a weaker market and lower freight rates and volumes in the Group’s Air & Sea freight forwarding operations.Adjusted EBITA amounted to MSEK 180 (217), which equaled an adjusted EBITA margin of 5.5 (6.0) percent.During the period, one-off items of MSEK -26 (-67) where charged to oper...
Albion Technology & General VCT PLC: Annual Financial Report
Albion Technology & General VCT PLC: Annual Financial Report Albion Technology & General VCT PLC LEI number: 213800TKJUY376H3KN16 As required by the UK Listing Authority's Disclosure Guidance and Transparency Rules 4.1 and 6.3, Albion Technology & General VCT PLC today makes public its info...
Elanders AB: Delårsrapport januari – mars 2024
Elanders AB: Delårsrapport januari – mars 2024 Första kvartalet 2024 Omsättningen uppgick till 3 268 (3 589) Mkr. Det motsvarade en organisk omsättningsminskning om nio procent, om förvärv samt nedlagd verksamhet exkluderas och oförändrade valutakurser används. Denna minskning var främst ett resultat av en svagare marknad samt lägre fraktpriser och volymer inom förmedlingen av Air & Sea-transporter.Justerad EBITA uppgick till 180 (217) Mkr, vilket motsvarade en justerad EBITA-marginal om 5,5 (6,0) procent.Rörelseresultatet belastades med engångsposter om -26 (-67) Mkr som huvudsa...
- Dominic Rose
- Naresh Chouhan
Sartorius Stedim - More Downside to Come (SELL, TP EUR150 [165], 9 pgs...
The capitulation may be upon us. The order book continues to show weakness & contrary to the befuddling Q423 sales strength, equipment sales look likely to stay weak as CDMO’s reduce CAPEX after 3yrs of turbo charged growth. We now question the trend growth rate as we believe that market share gains will be minimal, CDMO CAPEX will recover very slowly & M&A is unlikely to contribute as much as it did in the past. Moreover, we expect DIM to add significant capacity in the coming 24mths, which is ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.